Clinical Trial Update: Regadenoson R-T Perfusion Imaging Trial [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating regadenoson for perfusion imaging in coronary artery disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Lexiscan (regadenoson) (regadenoson)

Snippet

Sponsor: University of Nebraska | Conditions: Coronary Artery Disease, Myocardial Perfusion Abnormalities | Phase 1 | Status: COMPLETED | Results posted: 2024-12-24